The Motley Fool

Key Data Points

Primary metrics and data points about Geron Corp.
Current Price: $3.93
Prev Close: $3.93
Open: $0.00
Bid: $3.50
Ask: $4.20
Day's Range: $0.00 - $0.00
52wk Range: $1.69 - $4.49
Volume: 0
Avg Vol 2,793,334
Market Cap: $620M
P/E (ttm): -17.09
EPS (ttm): ($0.23)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Geron Corp from Fool.com.

Business Summary

Industry, sector and description for Geron Corp.

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

GERN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Geron Corp.
CAPS Rating 3 out of 5
 
632 Outperform
60 Underperform
CAPS All Stars
 
99 Outperform
19 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John A. Scarlett, CEO

100% Approve

Based on 1 Ratings

More Details for GeronJobs

Powered by

More Details about Geron Corp

Primary metrics and data points about Geron Corp.